| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |